Unique ID issued by UMIN | UMIN000041829 |
---|---|
Receipt number | R000047752 |
Scientific Title | Placebo-controlled, double-blind, randomized controlled trials that verify moisturizing effect of patients with atopic dermatitis by lotion containing plant extract. |
Date of disclosure of the study information | 2020/09/18 |
Last modified on | 2022/09/20 17:36:31 |
Verification test of Moisturizing effect for patients with atopic dermatitis.
Verification test of Moisturizing effect.
Placebo-controlled, double-blind, randomized controlled trials that verify moisturizing effect of patients with atopic dermatitis by lotion containing plant extract.
Placebo-controlled, double-blind, randomized controlled trials that verify moisturizing effect.
Japan |
Atopic dermatitis
Dermatology |
Others
NO
To evaluate the effect of continuous application for 12-weeks of the moisturizing lotion.
Safety,Efficacy
Stratum corneum water content
Skin observation by doctor
Transepidermal water loss
Microscope photography
Collecting stratum corneum
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Other |
Continuous application for 12-weeks two types of the moisturizing lotion (Placebo on the left, Lotion containing plant extract on the right).
Continuous application for 12-weeks two types of the moisturizing lotion (Placebo on the right, Lotion containing plant extract on the left).
20 | years-old | <= |
60 | years-old | >= |
Male and Female
1)Individuals with mild atopic dermatitis.
2)Individuals with dryness on the inside of the left and right forearms.
3)Individuals who agree to participate in this test after understanding the explanation of exam and show willingness to participate in the exam.
1)Individuals with moderate or higher atopic dermatitis.
2)Individuals who are taking orally steroids, antihistamine, anti-allergic agent, immunosuppressant, tranquilizers.
3)Individuals who have serious allergy by the use of topical drugs, cosmetics, quasi drugs and others in the past.
4)Individuals considered to be inappropriate for inclusion to have a serious illness.
5)Individuals who are being treated or hospitalized due to illness (Excluding colds and dentistry).
6)Individuals who have a family that are working at Pharmaceutical company or cosmetic company.
7)Individuals who are currently participating on survey using foods, cosmetics and quasi drugs, or are participating on any other clinical study, or have done so in the previous four weeks.
8)Individuals who are regarded to be inappropriate for this study by doctors.
20
1st name | Kayoko |
Middle name | |
Last name | Numano |
Numano Clinic
Dermatologist
370-0815
15, Yanagawachou, Takasaki-shi, Gunma, Japan
027-322-2926
kaco121@yahoo.co.jp
1st name | Takanori |
Middle name | |
Last name | Inai |
FUJI-SANGYO CO.,LTD
Research and Development Laboratory
763-0071
1301, Tamurachou, Marugame-shi, Kagawa, Japan
0877-25-3221
inai@fuji-sangyo.co.jp
FUJI-SANGYO CO.,LTD
FUJI-SANGYO CO.,LTD
Profit organization
General Incorporated Association Crinical Research Review Center
2972-8-603 Ishikawamachi Hachioji-shi,Tokyo,192-0032,JAPAN
090-3547-6398
crrctakashima@kpd.biglobe.ne.jp
NO
2020 | Year | 09 | Month | 18 | Day |
Unpublished
25
Completed
2020 | Year | 09 | Month | 09 | Day |
2020 | Year | 09 | Month | 09 | Day |
2020 | Year | 09 | Month | 18 | Day |
2020 | Year | 12 | Month | 25 | Day |
2020 | Year | 09 | Month | 17 | Day |
2022 | Year | 09 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047752
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |